Basic Information
| Clone | D3-L11 |
|---|
| Endotoxin | <1EU/mg (<0.001EU/μg)Determined by LAL gel clotting assay |
|---|
| Sterility | 0.2 μm filtration |
|---|
| Aggregation | <5% Determined by SECP |
|---|
| Purity | >95% Determined by SDS-PAGE |
|---|
Product Information
| Production | Purified from cell culture supernatant in an animal-free facility |
|---|
| Purification | Protein A or G purification |
|---|
| Storage | 2 - 8°C for up to 4 weeks and -80°C for long term storage (Avoid repeated freezing and thawing) |
|---|
Target Background
The anti-HEL VHH (hen egg-white lysozyme; nanobody, single-domain antibody, or the variable domain of heavy chain antibody) in nature is suitable for use as an isotype-matched control antibody to estimate the degree of non-specific binding by an antigen-specific antibody. As an ideal recombinant VHH isotype control antibody, the recombinant anti-HEL VHH isotype control antibody has low or no specific binding to any human and mouse sample. The recombinant anti-HEL VHH isotype control antibodies are useful for in vitro and in vivo studies from ELISA, cell-based assay to animal model study.
Immunogen Information
| Isotype | Mouse IgG2a Fc |
|---|
| Immunogen | hen egg-white lysozyme (HEL) |
|---|
| RecommendedIsotype Control(s) | In Vivo Grade Recombinant Mouse IgG2a Fc Protein |
|---|
| Recommended Dilution Buffer | 1×PBS pH 7.0 |
|---|
* For research use only. Not for therapeutic or diagnostic purposes.
